Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03093662 · ClinicalTrials.gov registry record · NA

Preoxygenation With Nasal Cannula and Noninvasive Positive Pressure Ventilation

A NA study of Hypoxia, sponsored by Brooke Army Medical Center.

Completed
Registry status
NA
Development phase
37
Enrollment target
1
Study location

NCT03093662 is a NA study of Hypoxia that has completed, run by Brooke Army Medical Center. The registered enrollment target is 37 participants, below the 3,116-participant average among 39 other Hypoxia trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03093662, a NA study of Hypoxia, has completed, sponsored by Brooke Army Medical Center.

COMPLETED
Registry status
NA
Development phase
37 participants
Enrollment target
1
Study location

Study Summary

This is a prospective randomized cross over study of healthy volunteers comparing end-tidal oxygen concentration among subjects undergoing continuous positive airway pressure ventilation via a noninvasive ventilation (NIV) mask with and without the addition of nasal cannulas.

Conditions Studied

Interventions

  • DEVICE Ventilation with nasal cannula
  • DEVICE Ventilation without nasal cannula

Study Locations (1)

Texas

  • Brooke Army Medical Center - Fort Sam Houston

Trial Details

FieldValue
Enrollment Target 37 participants
Start Date 2017-03-02
Est. Completion 2017-03-09
Phase NA

Sponsor

Brooke Army Medical Center

54 total trials

What the Registry Record Tells You About NCT03093662

The ClinicalTrials.gov registry entry for NCT03093662 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,116-participant average among 39 other Hypoxia trials with a reported enrollment target (99% lower). The listed sponsor is Brooke Army Medical Center, which has 54 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hypoxia appearing as the primary indexed condition, and to 2 interventions - of which Ventilation with nasal cannula is the first listed.

NCT03093662 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT03093662 about?

NCT03093662 is a clinical study titled "Preoxygenation With Nasal Cannula and Noninvasive Positive Pressure Ventilation". This is a prospective randomized cross over study of healthy volunteers comparing end-tidal oxygen concentration among subjects undergoing continuous positive airway pressure ventilation via a noninvasive ventilation (NIV) mask with and without the addition of nasal cannulas.

What is the current status of trial NCT03093662?

This trial is currently completed. It is a NA study. The enrollment target is 37 participants. The study started on 2017-03-02. Estimated completion is 2017-03-09.

What conditions does trial NCT03093662 study?

This clinical trial studies the following conditions: Hypoxia.

What interventions are being tested in trial NCT03093662?

The interventions under investigation include: Ventilation with nasal cannula (DEVICE), Ventilation without nasal cannula (DEVICE).

Who is sponsoring clinical trial NCT03093662?

This trial is sponsored by Brooke Army Medical Center, which has 54 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03093662 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypoxia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.